FDA Issues Strong Warning, Restricts Eligible Patients for Sarepta's Duchenne Gene Therapy Elevidys

FDA Issues Strong Warning, Restricts Eligible Patients for Sarepta’s Duchenne Gene Therapy Elevidys

FDA Issues Strong Warning, Restricts Eligible Patients for Sarepta's Duchenne Gene Therapy Elevidys